US Broker Ratings

GSK plc (GSK) Investor Outlook: Strong Dividend Yield and Strategic Growth in Healthcare

GSK plc (GSK), a stalwart in the healthcare sector and a major player in the drug manufacturing industry, offers investors a compelling mix of steady income..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Uncovering a 66% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector should consider Lantheus Holdings, Inc. (NASDAQ: LNTH), a company with a promising future reflected in its substantial potential upside...

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating the Healthcare Distribution Landscape with an 8.78% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare distribution sector, presents an intriguing proposition for investors seeking a firm foothold in the medical..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 263% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (PCVX), a clinical-stage biotechnology company, has captured the attention of investors with its pioneering approach to vaccine development. Specializing in conjugate and novel protein..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 70% Upside Potential Sparks Investor Interest

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a prominent entity in the biotechnology sector, dedicated to the development and commercialization of therapies for rare diseases. With..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth and Challenges with a 12.95% Upside

For investors seeking opportunities in the healthcare sector, Masimo Corporation (NASDAQ: MASI) presents an intriguing proposition. As a leading player in the medical devices industry, Masimo..

Qiagen N.V. (QGEN) Stock Analysis: Navigating a Promising 4.77% Upside in the Diagnostics Sector

Qiagen N.V. (QGEN), a Netherlands-based leader in the healthcare sector, is carving a niche in the diagnostics and research industry with its innovative molecular insights solutions...

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 35.76% Upside Potential in the Healthcare Sector

For investors keen on the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling opportunity. With a market capitalization of $13.91 billion, this American..

Inspire Medical Systems (INSP) Stock Analysis: Harnessing a 67.93% Potential Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the medical devices industry, is capturing attention with a significant potential upside of 67.93% based on..

Alkermes plc (ALKS) Investor Outlook: Analyzing a 33.87% Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, is drawing attention from investors with its significant potential upside of 33.87%, as indicated by..

STERIS plc (STE) Stock Analysis: Exploring the 9% Potential Upside in Healthcare Innovation

Investors with a keen eye on the healthcare sector might find STERIS plc (STE) an intriguing option. With its roots firmly planted in the medical devices..

Danaher Corporation (DHR) Stock Analysis: A 23% Upside Potential Awaits Investors

Danaher Corporation (NYSE: DHR), a leader in the healthcare sector, continues to captivate investor interest with its extensive portfolio in the diagnostics and research industry. With..

Bruker Corporation (BRKR) Stock Analysis: 46% Potential Upside in Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector’s medical devices industry, is catching the eye of investors with its promising potential upside. With..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Gem with 73.85% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands out in the biotechnology sector with its impressive pipeline and robust market presence. Based in Ireland, Jazz Pharmaceuticals specializes in..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Growth Potential with a Robust Dividend Strategy

HCA Healthcare, Inc. (HCA) stands as a stalwart in the U.S. healthcare sector, boasting a formidable market cap of $89.3 billion. As a leader in the..

Cencora, Inc. (COR) Investor Outlook: Navigating a 8.78% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector specializing in medical distribution, has captured investor attention with its robust market presence and promising..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating a 24.79% Upside Potential Amidst Market Challenges

Illumina, Inc. (NASDAQ: ILMN), a cornerstone in the healthcare sector, operates within the diagnostics and research industry. With a market cap of $13.76 billion, Illumina is..

Bio-Techne Corp (TECH) Stock Analysis: Unlocking 36.48% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) presents a compelling opportunity for investors seeking exposure to the burgeoning biotechnology sector. With a market capitalization of $7.92 billion, this Minneapolis-based..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising 78% Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) is drawing significant attention in the biotechnology sector, particularly among investors eager to capitalize on breakthroughs in precision oncology. With a..

Revvity, Inc. (RVTY) Investor Outlook: Unpacking a Promising 33% Potential Upside

Revvity, Inc. (RVTY), a key player in the Healthcare sector specializing in Diagnostics & Research, emerges as a compelling investment opportunity for those eyeing significant growth..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds